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a  b  s  t  r  a  c  t
The  purpose  of  this  study  was  to investigate  the  possibility  of  enhancing  the  solubilisation  capacity  of
micellar  solutions  of Pluronic  F127  for  the  poorly  water-soluble  drug  griseofulvin  by  co-formulating  with
a  water-soluble  polymer.  The  effect  of  the  addition  of the polyethylene  glycols  PEG6000  and  35000,  and
the  poly(vinylpyrrolidone)s  PVP  K30  and  K90,  on  the  solubilisation  capacity  of  1 wt%  solutions  of Pluronic





measurements.  The  addition  of PEG35000  to  1  wt%  F127  solutions  signiﬁcantly  increased  the  solubility
capacity  expressed  in terms  of unit  weight  of  F127;  PVP  K90  had  a smaller  effect  but no  enhancement
was  noted  following  the  addition  of  PEG6000  or PVP  K30.  Solubilisation  enhancement  was  thought  to  be
a  consequence  of  the  association  of the  polymers  with  the  E-blocks  of  the  micelle  corona  so  providing  an
expanded  region  of  reduced  polarity  for  drug  solubilisation.
© 2011 Elsevier B.V. Open access under the Elsevier OA license.
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. Introduction
Pluronic copolymers of ethylene oxide and propylene oxide,
ype EmPnEm, are available over a wide range of compositions and
lock lengths: we use the notation E = OCH2CH2, P = OCH2CH(CH3),
nd subscripts m and n to indicate number-average block lengths
n repeat units. Among their many applications is the solubilisa-
ion of poorly-soluble drugs in dilute aqueous micellar solutions
see, e.g., Chiappetta and Sosnik, 2007). As we have noted in
ecent reviews (Attwood et al., 2007; Attwood and Booth, 2007),
he solubility of hydrophobic drugs in dilute solutions of these
opolymers is lower than in micellar solutions of copolymers with
ore hydrophobic core-forming blocks, e.g. cores formed from 1,2-
utylene oxide or styrene oxide. However, such copolymers are
ot readily available and a simple means of improving the perfor-
ance of Pluronic copolymers would be useful. Recently (Oliveira
t al., 2011) we reported a signiﬁcant increase in the solubilisation
apacity of 1 wt%  micellar solutions of copolymer F127 (E98P67E98)
or the aromatic drug griseofulvin (see Scheme 1) on addition
f a small quantity (0.5 wt%) of polyethylene glycol PEG35000.
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poly(vinylpyrrolidone) PVP K30 the solubilisation capacity for
griseofulvin was  not increased signiﬁcantly. We  deﬁne the solu-
bilisation capacity as (S − So)/wt expressed in mg  g−1, where S is
the solubility of the drug in the solution, So the solubility in water,
and wt the total weight of copolymer plus polymer. We  focus on
the solubilisation of griseofulvin as it has poor water solubility and
has long been used (Elworthy and Patel, 1982; Rekatas et al., 2001)
as a standard for testing micellar hosts.
In this paper, we  report the results of a broader investigation
of these effects, maintaining our interest in copolymer F127 as the
source of micelles and griseofulvin as the solubilised drug, but with
PVP and PEG samples with different molar masses studied over a
wider range of concentrations. Also included is an investigation of
the effect of addition of the polymers on the micelles as determined
by dynamic light scattering measurements.
2. Experimental
2.1. MaterialsGriseofulvin was  obtained from Sigma–Aldrich, Poole, Dorset,
UK) and was used in the form of ﬁnely ground (1 mm2 mesh)
powder. Differential scanning calorimetry indicated one crystalline









orm with a melting point of 220.4 ◦C and an enthalpy of fusion
f 115.6 J g−1. There was no detectable transition consistent with glassy component. Triblock copolymer F127, a product of BASF
orp. and purchased from Sigma–Aldrich, was used as received.
he value of the number-average molar mass supplied with the
ample was 12,500 g mol−1. A value of the ratio of weight- to
ig. 1. Intensity distributions from DLS: intensity-fraction versus the logarithm of apparen
EG6000,  PEG35000, PVP K30 and PVP K90, as indicated. T = 40 ◦C. Pharmaceutics 421 (2011) 252– 257 253
number-average molar mass, Mw/Mn = 1.20, was  determined by gel
permeation chromatography (GPC) using N,N-dimethylacetamide
(DMA) at 70 ◦C as solvent and poly(ethylene oxide) calibrants,
as described previously (Chaibundit et al., 2000). The polymers
were also obtained via Sigma–Aldrich, PEG6000 and PEG35000
from Sigma, PVP K30 and PVP K90 from Fluka. Our  check of
the polyethylene glycols by GPC, using DMA  solvent at 70 ◦C
and poly(ethylene oxide) calibrants, yielded distribution widths
(Mw/Mn) of 1.07 (PEG6000) and 1.16 (PEG35000). The molecular
characteristics reported for PVP, both in the technical literature
and in publications (Haaf et al., 1985; Segre et al., 1998; Xu et al.,
1999; Zeng et al., 2001) vary considerably. Values of the ratio
Mw/Mn determined for our samples using GPC with DMA/LiNO3
at 70 ◦C as solvent and poly(ethylene oxide) calibrants were 2.8
for PVP K30 and 3.6 for PVP K90, much as expected for sam-
ples known to have broad chain length distributions. Adopting the



























































chains and in more concentrated solutions this leads to the PEG
chains bridging between micelles to form clusters. It should be
noted that values of rh,app include contributions from particle inter-
action, and are also affected by any increase in viscosity caused by54 C.P. Oliveira et al. / International Jour
anufacturers’ values of Mw ≈ 40,000 and 360,000 g mol−1 for
VP K30 and PVP K90 respectively, our values of Mw/Mn lead to
n ≈ 14,000 and 100,000 g mol−1 for the two polymers.
.2. Solubilisation of griseofulvin
A  stock solution of 1 wt% F127 in water was used to prepare
urther stock solutions containing amounts of PEG6000, PEG35000
nd PVP K30 in the range 0–10 wt%, and of PVP K90 in the range
.5–5 wt% to avoid the very viscous solutions of this polymer
t higher concentrations. Corresponding solutions were prepared
ithout F127. Powdered griseofulvin (10 mg)  was mixed with stock
olution (10 ml), and the mixture was stirred at constant tem-
erature (37 ◦C) for 48 h before being ﬁltered (0.45 m Millipore
lters) to remove unsolubilised drug. The procedure is equivalent
o the standard Shake-Flask method. The extent of solubilisation
t 37 ◦C was determined by UV spectroscopy, a method which has
een checked against other procedures, e.g. 1H NMR  spectroscopy
Crothers et al., 2005) and liquid chromatography (Zhou et al.,
008). The drug-loaded solutions were diluted quantitatively with
ufﬁcient methanol to enable determination of the absorbance at
ptimum wavelength (griseofulvin 292 nm), and this absorbance
as compared with the Beer’s Law plot for griseofulvin in methanol.
he water content after dilution was low enough to allow the cal-
bration with methanol solutions to be used without correction.
lank experiments (no F127) gave the solubility of the drug in water
r in polymer solution. The uncertainty in an individual measure-
ent was ca. ±1.5 g dl−1, hence measurements were carried out in
riplicate and the results were averaged.
.3. Dynamic light scattering
Solutions  containing 1 wt% F127 and the polymers at concen-
rations in the range 0–10 wt% (PVP K90 0–5 wt%) were clariﬁed
or light scattering by ﬁltering through Millipore Millex ﬁlters
Triton free, 0.22 m)  directly into the cleaned scattering cell. In
ertain experiments, the most concentrated solution was ﬁltered
nd subsequently diluted with ﬁltered water. Dynamic light scat-
ering (DLS) measurements were made at 40 ◦C with incident light
f wavelength 488 nm (Coherent Innova Argon ion laser) using
 Brookhaven BI-HV goniometer combined with a Brookhaven
I9000AT digital correlator to acquire data. The duration of the
xperiment was 10 min, and each experiment was repeated two
r more times. Scattered light intensity was measured at an angle
 = 90◦ to the incident beam.
The correlation functions from DLS were analyzed by the con-
trained regularized CONTIN method (Provencher, 1979) to obtain
istributions of decay rates ( ), from which distributions of appar-
nt mutual diffusion coefﬁcient [Dapp =  /q2, q = (4n/)sin(/2),
 = refractive index of the solvent,  = wavelength] were deter-
ined. The apparent hydrodynamic radius (rh,app, radius of the
ydrodynamically equivalent hard sphere corresponding to Dapp)





here  k is the Boltzmann constant and  is the viscosity of the
edium at temperature T. Anticipating association of the polyethy-
ene glycols with the micelles, similar to that reported for CnEm
Feitosa et al., 2002) and the related Triton X-100 copolymer
Ge et al., 2007), we assumed that the solvent was water and
sed the viscosity of water in our analysis. In practice intensities
( ) delivered by the CONTIN program at logarithmically spaced
alues of the decay rate were transformed to I(log  ) = I( )
o obtain intensity distributions of log( ) and hence of
og(rh,app). Normalization of I(log rh,app) gave the intensity fraction Pharmaceutics 421 (2011) 252– 257
distributions presented in Section 3.1. Average values of rh,app were
delivered by the program.
3.  Results and discussion
3.1.  Apparent hydrodynamic radius
The intensity fraction distributions of log(rh,app) obtained for
aqueous solutions containing 1 wt% of F127 and 0.5–10 wt%  of each
of the four polymers are illustrated in Fig. 1. Temperatures were
held at 40 ◦C, approximating the temperature of 37 ◦C used for the
solubilisation experiments. Small peaks at low values of log(rh,app)
in the distributions of the samples with the highest concentrations
of PEG were not reliably reproduced and were not included.
As  illustrated in Fig. 1, the intensity distributions shifted to
higher values of log(rh,app) as the concentration of PEG was
increased, and to lower values of log(rh,app) as the concentration
of PVP was  increased. This effect is reproduced in the intensity-
average values of rh,app obtained from the CONTIN output for the
four copolymer and plotted in Fig. 2. The intensity-average deliv-
ered by the CONTIN program includes the full range of particle sizes
– polymers, micelles and clusters. The intensity weighting (essen-
tially z-weighting) means that the contribution to the DLS signal
from micelles, and particularly that from micelle clusters, greatly
outweighs that from any residual polymer chains.
The increase in rh,app resulting from the presence of PEG6000
and PEG35000 in micellar solutions of F127 is consistent with
related results from DLS for micellar solutions of C12E8 with
0–5 wt%  PEG12000 (Feitosa et al., 2002) and for solutions of Tri-
ton X-100 (C8PhE10) with 5 wt% PEG (range 400–20,000) (Ge
et al., 2007). It is also consistent, with results from DLS for a
range of polyethylene glycols and a diblock copolymer formed by
coupling ibuprofen (C12CO overall) to PEG800 (E18) (Wei  et al.,
2010). Polyethylene glycols are compatible with the E-blocks of
the micelle corona, and the implication is that in dilute PEG solu-
tions micelle coronae are favoured as an environment for the PEGFig. 2. The effect of addition of () PEG6000, (©) PEG35000, () PVP K30 and ()
PVP  K90 on the apparent hydrodynamic radii of particles in aqueous solutions of 1
wt% F127: () indicates 1 wt% F127 alone. T = 40 ◦C.






















eig. 3. The solubility (S) of griseofulvin in aqueous solutions of either () the polym
he eye through the points.
nassociated PEG chains, but this complication does not preclude
ualitative interpretation of the results.
To understand the driving force for association of PEG with
he chains of the micelle corona it is necessary to bear in mind
hat the oxyethylene chain is predominantly hydrophobic yet it is
eadily soluble in dilute aqueous solution when the water is struc-
ured by hydrogen bonding, as it will be at 40 ◦C. As summarised
ome time ago (Marinov and Marsuura, 2002) the solubility of
oly(oxyethylene) in dilute solution arises from the fact that the
istance between the oxygen atoms of the oxyethylene chain in
auche conformation almost coincides with the distance between
he oxygen atoms of neighbouring molecules in structured water,
llowing the E-chains to participate in the H-bonded structure.
owever, the coincidence of distance is not perfect and not all
xyethylene groups are in the gauche conformation, hence the
esidual hydrophobic effect in dilute solution which causes associ-
tion of PEG35000 with the micelle.
PVP is not compatible with the E-blocks of the micelle corona
nd association is restricted. Indeed coincidence of the enthalpy
hanges detected by isothermal titration calorimetry of micellar
olutions of copolymer C12E6 with and without added PVP K90 (Li
t al., 2000) indicates that interaction of PVP with the E-blocks inlone or () the polymers plus 1 wt% F127. T = 37 ◦C. The curves are included to lead
the  micelle coronae is enthalpically neutral. In contrast, a nega-
tive enthalpic effect is well established when PVP binds to micelles
carrying charges, such as those formed from sodium dodecyl sul-
phate (SDS) (Li et al., 2000). The shift of the intensity distribution
to lower values of log(rh,app) (Fig. 1) can be assigned to the micelles
maintaining their separate identity with the effect of the increase
in viscosity of the solvent (see Eq. (1)) reinforced by an increase in
the proportion of chains included within the main peak taking the
intensity average to smaller values.
3.2. Solubilisation of griseofulvin
3.2.1.  Solubility
Fig.  3 illustrates values obtained for the solubility of griseofulvin
in 0.5–10 wt%  aqueous solutions of the four polymers at T = 37 ◦C
and also in the same range of solutions but including 1 wt% F127.
The quantity plotted (S − So, mg  dl−1) is the solubility in excess of
that in water alone, where S is the solubility in solution and So
is the solubility of griseofulvin in water. As noted in Section 2.2,
measurements were carried out in triplicate giving an uncertainty
in the resulting average of ca. ±0.5 mg  dl−1 for PEG6000, PEG35000
256 C.P. Oliveira et al. / International Journal of
Fig. 4. Solubilisation capacities for solubilisation of griseofulvin of aqueous solu-
tions of 1 wt%  F127 and () PEG6000, (©) PEG35000, () PVP K30 or () PVP K90. The
solubilisation capacity st = (S − So)/wt (mg  g−1), where So is the solubility of griseoful-





































5.  Conclusion = 37 ◦C. The curves are included to lead the eye through the points. The dotted line
ndicates the solubilisation capacity of F127 alone in water.
nd PVP K30 but with values as high as ±1 mg  dl−1 for the more
iscous solutions of PVP K90.
In water alone, the excess solubility increased almost linearly
or PEG6000 and PVP K30 to reach ca. 3 or 5 mg  dl−1 respectively at
0 wt% polymer. Values of (S − So) increased slowly for PEG35000
nd PVP K90 in the range 0–2 wt%, but more rapidly thereafter to
each 2 mg  dl−1 for PVP K90 at 5 wt% and a little higher, 3–4 mg  dl−1,
or PEG35000 in the range 5–10 wt%.
The effect of inclusion of 1 wt% F127 in water was an immediate
ncrease in solubility to 3.1 mg  dl−1. The almost linear increase in
olubility with polymer concentration recorded for PEG6000 over
he whole concentration range was essentially reproduced in the
ixed solvent, and following a more rapid increase to 4.5 g dl−1 at
 wt% the linear increase in (S − So) with concentration observed
or PVP K30 also mirrored that of the polymer in water (see Fig. 3a
nd c). For PEG35000 and 1 wt% F127 (Fig. 3b) values of (S − So)
ncreased rapidly to ca.7 mg  dl−1 at 0.5 wt% polymer and this value
as maintained to 7 wt% PEG35000 until a further steady increase
o (S − So) ≈ 8.5 mg  dl−1 at 10 wt%. For PVP K90 (Fig. 3d) a rapid
ncrease to (S − So) ≈ 5.5 mg  dl−1 at 1 wt% polymer was  maintained
o 5 wt% polymer, which is the limit of the measurements for this
ystem.
.2.2. Solubilisation capacity
In  pharmaceutical practice, the need is to minimise the amount
f excipient needed to solubilise an effective amount of drug, and
he important quantity is the solubilisation capacity of the copoly-
er/polymer mixture, deﬁned here as st = (S − So)/wt (mg  g−1)
here S − So (mg  dl−1) is the increased solubility of griseofulvin
ver that in water and wt is the total concentration of copolymer
lus polymer in solution (mg  dl−1). Therefore we look for values of
he solubilisation capacity exceeding that of a 1 wt%  micellar solu-
ion of F127 alone, i.e. st ≈ 3.1 mg  g−1. Values of st for the polymers
lone in water are lower than 1 mg  g−1 across the concentration
ange. Values of st for the polymers with 1 wt% F127 are illustrated
n Fig. 4 for the concentration range 0–5 wt%; at higher concen-
rations values continue their steady decrease. The dotted line
ndicates the solubilisation capacity determined for F127 alone in Pharmaceutics 421 (2011) 252– 257
water,  and it is seen that solutions with 0.5 and 1 wt% PEG35000
and 0.5 wt%  PVP K90 exceed that value.
4.  Discussion
Usually the solubilisation of hydrophobic drugs in aqueous solu-
tions of block copolymers is related to the formation of micelles
stabilised by a corona of E-blocks with the hydrophobic cores
being the major site of a solubilised hydrophobic drug and the
poly(oxyethylene) corona making only a minor contribution (see,
e.g. Crothers et al., 2005). The large increase in solubility of
hydrophobic griseofulvin in aqueous solutions of 1% F127 on addi-
tion of PEG35000 and PEG6000 may  be a consequence of the
association of the E-chains of PEG with the E-blocks of the micelle
corona thus providing an expanded region of reduced polarity for
drug solubilisation. As seen in Fig. 3b, for solutions containing
PEG35000 and F127 the value of S − So is almost constant at about
7 mg  dl−1 across the range of PEG35000 concentration from 0.5 to
7 wt%, which is consistent with the swollen micelle coronae being
fully saturated with griseofulvin when the PEG35000 concentration
reaches 0.5 wt%, with further increase in particle size (see Fig. 2)
attributable to the formation of micelle clusters. Further increase
in S as the PEG35000 concentration is increased beyond 7 wt% can
be related to the increase observed at high PEG35000 concentra-
tions in the absence of F127 (see Fig. 3b), i.e. the polymer solution
as a whole is taking up the drug. Indeed, judging by the parallel
behaviour seen for solutions of PEG6000 with and without F127
in Fig. 3a, association of PEG6000 with the E-blocks of the micelle
corona is not a major mechanism for the increase in solubilisation
on addition of PEG6000.
The  mechanism of solubilisation by F127 and PVP K30 or PVP
K90 is less obvious. It is clear from the spectroscopic study of
drug/PVP blends (Nair et al., 2001) that there is no strong inter-
action between griseofulvin and PVP K90, and our solubilisation
measurements for griseofulvin in solutions of PVP alone bear this
out. However, the inclusion of micellar F127 in a solution of PVP
increases griseofulvin solubility, markedly so for solutions of PVP
K90 (see Fig. 3d). Moreover, as noted in Section 3 there are strik-
ing similarities between the solubility curves for griseofulvin in
solutions of F127 micelles and the two  lower molecular weight
polymers (PEG6000 and PVP K30, Fig. 3a and c) on the one hand and
between corresponding curves for the two  higher molecular weight
polymers (PEG35000 and PVP K90, Fig. 3b and d) on the other, most
notably in the sharp increase in solubility at polymer concentra-
tion 0.5 wt%  recorded for both PEG35000 and PVP K90. Our  DLS
measurements provide no direct evidence for association of PVP
with F127 micelles (see Fig. 2 and related discussion). However,
if, as discussed in the previous paragraph, we  assign the marked
increase in rh,app observed for the F127/PEG system to the forma-
tion of micelle clusters then association of PVP with the corona of
the micelles is not ruled out. Indeed, from a thermodynamic view-
point transfer of PVP from dilute aqueous solution to the micelle
corona is likely, because hydrophobically-bonded water around the
largely-hydrophobic PVP chains, and also structured water around
the E-blocks of the micelle corona, will be released with the con-
sequent decrease in Gibbs energy of the whole system driving the
association. The effect for the lengthy chains of PVP K90 will be
much greater than for the shorter chains of PVP K30. Solubilisation
of hydrophobic griseofulvin in micelle corona swollen with PVP K90
will then follow a parallel path to that described for PEG35000.We  note that the value of S − So = 7.0 mg  dl−1 reported for a solu-
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f 6.1 mg  dl−1 found in related work for a 2.5 wt% solution of F127
lone, in fact similar to the value expected for a 3 wt%  solution of
127 alone. In terms of the solubilisation capacity, st = (S − So)/wt
mg  g−1), that of 1 wt% F127 alone is st ≈ 3 mg  g−1 while that of
 wt% F127 and 0.5 wt% PEG35000 is st = 4.9 mg  g−1. Of the other
hree polymers investigated, only the solubilisation capacity of
 wt% F127 and 0.5 wt% PVP K90 exceeds that of 1 wt% F127. The use
f high concentrations of surfactants for drug delivery is pharma-
eutically undesirable as well as costly; it is therefore of interest to
ote from our study that the addition of a relatively small amount of
EG35000 (or to a lesser extent PVP K90), allows a smaller quantity
f F127 to be used for solubilisation while still achieving a similar
r enhanced solubilisation capacity.
Since the most signiﬁcant solubilisation enhancement noted in
his study derives essentially from interaction of the high molec-
lar weight PEG with the oxyethylene chains of the corona of the
127 micelles, it would be expected that other micelle forming EPE
opolymers should behave in a similar manner.
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